期刊文献+

超高效液相色谱-质谱联用法同时测定人血浆中美托洛尔及其代谢物的浓度 被引量:4

Simultaneous determination of metoprolol and its metabolites in human plasma by ultra-performance liquid chromatography-tandem mass spectrometry
原文传递
导出
摘要 目的建立超高效液相色谱-质谱联用法(UPLC-MS/MS)定量测定人血浆中美托洛尔及其代谢产物(α-羟基美托洛尔、O-去甲基美托洛尔)的方法。方法采用乙酸乙酯从100μL血浆中提取分析物及内标(d7-美托洛尔),色谱柱:UPLC HSS T3柱(3.0 mm×100 mm,1.8μm),柱温:30℃,流动相:5mmol·L^(-1)醋酸铵+0.2%甲酸与乙腈,梯度洗脱,流速:0.30 m L·min^(-1);质谱采用正离子模式(ESI),多反应监测模式进行检测。结果美托洛尔的标准曲线方程为y=1.56×10^(-1)x-4.80×10^(-2),在0.2~100.0 ng·m L^(-1)范围内线性关系良好,定量下限为0.2 ng·m L^(-1);α-羟基美托洛尔的标准曲线为y=1.06×10^(-1)x^(-1).30×10^(-2),在0.2~100.0 ng·m L^(-1)范围内线性关系良好,定量下限为0.2 ng·m L^(-1);O-去甲基美托洛尔的标准曲线为y=4.40×10^(-2)x^(-1).10×10^(-2),在0.1~50.0 ng·m L^(-1)范围内线性关系良好,定量下限为0.1ng·m L^(-1)。美托洛尔、α-羟基美托洛尔、O-去甲基美托洛尔的平均绝对回收率分别为64.7%,51.7%,55.4%。批间及批内精密度的相对标准差均小于15%,稳定性良好。该方法成功测定了90例服药患者的美托洛尔及其两种代谢产物的稳态血药浓度。结论该方法敏感,快速,血浆消耗量少,可用于临床用药监测及其相关研究。 Objective A rapid and sensitive ultra-performance liquid chromatography-tandem mass spectrometry( UPLC-MS/MS) assay was developed and validated for the simultaneous quantification of metoprolol and its metabolites( α-Hydroxy metoprolol and O-desmethyl metoprolol) in human plasma. Methods Sample was prepared by liquid-liquid extraction with ethyl acetate from 100 μL plasma. Chromatographic column: UPLC HSS T3 column( 3. 0 mm × 100 mm,1. 8 μm),column temperature: 30℃,mobile phase: 5 mmol · L^(-1) ammonium acetate +0. 2% formic acid, gradient acetonitrile at a flow rate of 0. 30 m L·min^(-1). Mass spectrometry detection was performed through positive ion electrospray ionization( ESI),multiple reaction monitoring mode.Results The regression equations of metoprolol,α-Hydroxy metoprolol and O-desmethyl metoprolowere y = 1. 56 × 10^(-1) x-4. 80 × 10^(-2),y = 1. 06 × 10^(-1) x^(-1). 30 × 10^(-2),y = 4. 40 × 10^(-2) x^(-1). 10 × 10^(-2),respectively. They all showed good linearities in the ranges of 0. 2^(-1)00. 0 ng·m L^(-1),0. 2^(-1)00. 0 ng·m L^(-1),and 0. 1-50. 0 ng·m L^(-1),respectively. Their lower limits of quantification were0. 2 ng·m L^(-1),0. 2 ng·m L^(-1),and 0. 1 ng·m L^(-1),respectively. Mean absolute recoveries were 64. 7%,51. 7%,55. 4% for metoprolol,α-Hydroxy metoprolol,O-desmethyl metoprolol,respectively. RSD of intra and inter precision and accuracy were less than 15% and stability was good. It was successfully applied to determine steady state concentrations of metoprolol and its two metabolites for 90 patients treated with metoprolol. Conclusion This method is sensitive,less time consuming,less plasma consuming,suitable for clinical monitor or study of metoprolol.
作者 白雪 朱茜 李汉平 雷和平 张斌 黄民 钟诗龙 BAI Xue;ZHU Qian;LI Han-ping;LEI He-ping;ZHANG Bin;HUANG Min;ZHONG Shi-long(Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention,Guangdong Academy of Medical Sciences,Guangdong General Hospital,Guangzhou,Guangdong 510080,China;Institute of Clinical Pharmacology,School of Pharmaceutical Sciences,Sun Yat-sen University,Guangzhou,Guangdong 510006,China;School of Medicine,South China University of Technology,Guangzhou,Guangdong 510006,China)
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2018年第15期1906-1910,共5页 The Chinese Journal of Clinical Pharmacology
基金 国家自然科学基金资助项目(81673514 81373486) 国家重点研发计划基金资助项目(2017YFC0909301 2017YFC0909302 2017YFC0909303 2016YFC0905003) 广东省科技计划项目基金资助项目(2016B090918114) 广州市科技计划基金资助项目(201510010236 201604020096)
关键词 美托洛尔 α-羟基美托洛尔 O-去甲基美托洛尔 血药浓度 metoprolol α- Hydroxy metoprolol O- desmethyl metoprolol plasma concentrations
  • 相关文献

参考文献1

二级参考文献19

  • 1Dumasia MC. In vivo biotransformation of metoprolol in horse and on-column esterification of the aminocarboxylic acid metabolite by alcohols during solid phase extraction using mixed mode columns. J Pharm Biomed Anal 2006; 40: 75-81.
  • 2Lennard MS, Tucker GT, Woods HF. The polymorphic oxidation of beta-adrenoceptor antagonists. Clinical pharmacokinetic considerations. Clin Pharmacokinet 1986; 11: 1-17.
  • 3Lisowska K, Szemraj J, Rozalska S, Dlugonski J. The expression of cytochrome P-450 and cytochrome P-450 reductase genes in the simultaneous transformation of corticosteroids and phenanthrene by Cunninghamella elegans. FEMS Microbiol Lett 2006; 261:175-80.
  • 4Zhang D, Zhang H, Aranibar N, Hanson R, Huang Y, Cheng PT, et al. Structural elucidation of human oxidative metabolites of muragli-tazar: use of microbial bioreactors in the biosynthesis of metabolite standards. Drug Metab Dispos 2006; 34: 267-80.
  • 5Lisowska K, Dlugonski J, Freeman JP, Cerniglia CE. The effect of the corticosteroid hormone cortexolone on the metabolites produced during phenanthrene biotransformation in Cunninghamella elegans. Chemosphere 2006; 64: 1499-506.
  • 6Chen Y, Monshouwer M, Fitch WL. Analytical tools and approaches for metabolite identification in early drug discovery. Pharm Res 2007; 24: 248-57.
  • 7Sun L, Huang HH, Liu L, Zhong DF. Transformation of verapamil by Cunninghamella blakesleana. Appl Environ Microbial 2004; 70: 2722-7.
  • 8Xie ZY, Huang HH, Zhong DF. Biotransformation of pantoprazole by the fungus Cunninghamella blakesleana. Xenobiotica 2005; 35: 467-77.
  • 9Zhang P, Lin LH, Huang HH, Xu HY, Zhong DF. Biotransformarion of indomethacin by the fungus Cunninghamella blakesleeana. Acta Pharmacol Sin 2006; 27: 1097-102.
  • 10Kulkarni VM, Coutinho EC. Conformational analysis of atenolol and metoprolol by ^1H NMR. Indian J Chem 1991; 30: 52-6.

共引文献4

同被引文献34

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部